bf/NASDAQ:SABS_icon.jpeg

NASDAQ:SABS

SAB Bio

  • Stock

USD

Last Close

3.10

06/11 21:00

Market Cap

29.53M

Beta: 1.26

Volume Today

9.11K

Avg: 1.39M

PE Ratio

−10.36

PFCF: 7.38

OverviewFinancialsAPI

    Description

    SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -3-2-12021-04-022022-05-122023-05-162024-03-252024-08-192025-05-19

    Revenue (Estimate*)

    10M20M30M40M50M60M2021-04-022022-05-122023-05-162024-03-252024-08-192025-05-19

    *Estimate based on analyst consensus